These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 34529698

  • 1. Revisiting the placental clock: Early corticotrophin-releasing hormone rise in recurrent preterm birth.
    Herrera CL, Bowman ME, McIntire DD, Nelson DB, Smith R.
    PLoS One; 2021; 16(9):e0257422. PubMed ID: 34529698
    [Abstract] [Full Text] [Related]

  • 2. Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation.
    Wadhwa PD, Garite TJ, Porto M, Glynn L, Chicz-DeMet A, Dunkel-Schetter C, Sandman CA.
    Am J Obstet Gynecol; 2004 Oct; 191(4):1063-9. PubMed ID: 15507922
    [Abstract] [Full Text] [Related]

  • 3. Elevated maternal plasma corticotropin releasing hormone levels in twin gestation.
    Warren WB, Goland RS, Wardlaw SL, Stark RI, Fox HE, Conwell IM.
    J Perinat Med; 1990 Oct; 18(1):39-44. PubMed ID: 2348330
    [Abstract] [Full Text] [Related]

  • 4. Placental histology for targeted risk assessment of recurrent spontaneous preterm birth.
    Suresh S, Freedman A, Adams M, Hirsch E, Ernst LM.
    Am J Obstet Gynecol; 2024 Apr; 230(4):452.e1-452.e11. PubMed ID: 37751829
    [Abstract] [Full Text] [Related]

  • 5. Placental pathology, corticotropin-releasing hormone, timing of parturition, and fetal growth in the pregnancy outcomes and community health study.
    Perng W, Holzman C, Talge NM, Senagore PK.
    J Matern Fetal Neonatal Med; 2020 Apr; 33(7):1225-1232. PubMed ID: 30157679
    [Abstract] [Full Text] [Related]

  • 6. Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm delivery.
    Sibai B, Meis PJ, Klebanoff M, Dombrowski MP, Weiner SJ, Moawad AH, Northen A, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S, Maternal Fetal Medicine Units Network of the National Institute of Child Health and Human Development.
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1181-6. PubMed ID: 16157134
    [Abstract] [Full Text] [Related]

  • 7. Maternal plasma corticotropin-releasing hormone associated with stress at 20 weeks' gestation in pregnancies ending in preterm delivery.
    Hobel CJ, Dunkel-Schetter C, Roesch SC, Castro LC, Arora CP.
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 3):S257-63. PubMed ID: 9914629
    [Abstract] [Full Text] [Related]

  • 8. 17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study.
    Nelson DB, McIntire DD, McDonald J, Gard J, Turrichi P, Leveno KJ.
    Am J Obstet Gynecol; 2017 Jun; 216(6):600.e1-600.e9. PubMed ID: 28223163
    [Abstract] [Full Text] [Related]

  • 9. CRH as a Predictor of Preterm Birth in Minority Women.
    Ruiz RJ, Gennaro S, O'Connor C, Dwivedi A, Gibeau A, Keshinover T, Welsh T.
    Biol Res Nurs; 2016 May; 18(3):316-21. PubMed ID: 26512053
    [Abstract] [Full Text] [Related]

  • 10. Elevated maternal cortisol early in pregnancy predicts third trimester levels of placental corticotropin releasing hormone (CRH): priming the placental clock.
    Sandman CA, Glynn L, Schetter CD, Wadhwa P, Garite T, Chicz-DeMet A, Hobel C.
    Peptides; 2006 Jun; 27(6):1457-63. PubMed ID: 16309788
    [Abstract] [Full Text] [Related]

  • 11. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
    Manuck TA, Esplin MS, Biggio J, Bukowski R, Parry S, Zhang H, Huang H, Varner MW, Andrews W, Saade G, Sadovsky Y, Reddy UM, Ilekis J, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Genomics and Proteomics Network for Preterm Birth Research (GPN-PBR).
    Am J Obstet Gynecol; 2016 Mar; 214(3):376.e1-8. PubMed ID: 26692181
    [Abstract] [Full Text] [Related]

  • 12. Pregnancy duration with use of 17-α-hydroxyprogesterone caproate in a retrospective cohort at high risk of recurrent preterm birth.
    Massa K, Childress K, Vricella LK, Boerrigter A, Franklin BHK, Sauer M, Armbruster R, Tomlinson T.
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100219. PubMed ID: 33345927
    [Abstract] [Full Text] [Related]

  • 13. Associations Between Placental Corticotropin-Releasing Hormone, Maternal Cortisol, and Birth Outcomes, Based on Placental Histopathology.
    Johnston RC, Faulkner M, Carpenter PM, Nael A, Haydel D, Sandman CA, Wing DA, Davis EP.
    Reprod Sci; 2020 Sep; 27(9):1803-1811. PubMed ID: 32219714
    [Abstract] [Full Text] [Related]

  • 14. Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy.
    Wadhwa PD, Porto M, Garite TJ, Chicz-DeMet A, Sandman CA.
    Am J Obstet Gynecol; 1998 Oct; 179(4):1079-85. PubMed ID: 9790402
    [Abstract] [Full Text] [Related]

  • 15. Pregnancy anxiety predicts shorter gestation in Latina and non-Latina white women: The role of placental corticotrophin-releasing hormone.
    Ramos IF, Guardino CM, Mansolf M, Glynn LM, Sandman CA, Hobel CJ, Dunkel Schetter C.
    Psychoneuroendocrinology; 2019 Jan; 99():166-173. PubMed ID: 30245329
    [Abstract] [Full Text] [Related]

  • 16. Corticotrophin-releasing hormone and CRH-binding protein. Differences between patients at risk for preterm birth and hypertension.
    Hobel CJ, Arora CP, Korst LM.
    Ann N Y Acad Sci; 1999 Jan; 897():54-65. PubMed ID: 10676435
    [Abstract] [Full Text] [Related]

  • 17. Maternal prenatal anxiety and corticotropin-releasing hormone associated with timing of delivery.
    Mancuso RA, Schetter CD, Rini CM, Roesch SC, Hobel CJ.
    Psychosom Med; 2004 Jan; 66(5):762-9. PubMed ID: 15385704
    [Abstract] [Full Text] [Related]

  • 18. Second trimester corticotropin-releasing hormone levels in relation to preterm delivery and ethnicity.
    Holzman C, Jetton J, Siler-Khodr T, Fisher R, Rip T.
    Obstet Gynecol; 2001 May; 97(5 Pt 1):657-63. PubMed ID: 11339911
    [Abstract] [Full Text] [Related]

  • 19. The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth.
    Bustos ML, Caritis SN, Jablonski KA, Reddy UM, Sorokin Y, Manuck T, Varner MW, Wapner RJ, Iams JD, Carpenter MW, Peaceman AM, Mercer BM, Sciscione A, Rouse DJ, Ramin SM, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
    Am J Obstet Gynecol; 2017 Sep; 217(3):369.e1-369.e9. PubMed ID: 28522317
    [Abstract] [Full Text] [Related]

  • 20. Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery.
    Sasaki A, Shinkawa O, Margioris AN, Liotta AS, Sato S, Murakami O, Go M, Shimizu Y, Hanew K, Yoshinaga K.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):224-9. PubMed ID: 3491832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.